Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 5/20 | 0.72 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.70 |
| ▸ | DPP4 | P27487 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.70 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.70 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.70 |
| ▸ | GAPDH | P04406 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | STAT6 | P42226 | 1/20 | 0.70 |
| ▸ | PI4KA | P42356 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.70 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.70 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.70 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15798541 | 1.00 | AHCY (0.72) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL15371596 | 1.00 | AHCY (0.72) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL11443305 | 0.89 | AHCY (0.70) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL18862676 | 0.87 | AHCY (0.70) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL926262 | 0.87 | AHCY (0.68) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL2113154 | 0.87 | AHCY (0.70) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL10304700 | 0.87 | AHCY (0.70) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL10997946 | 0.86 | ADORA1 (0.76) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL12963362 | 0.86 | ADORA1 (0.76) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A | |
| SCHEMBL5024895 | 0.86 | ADORA1 (0.76) | AHCYADORA1SMN1; SMN2ADORA3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3863609-A1 | SMALL POLYMERIC CARRIERS FOR DELIVERY OF AGENTS | University of Pittsburgh - Of the Commonwealth System of Higher Education (US) | 2021-08-18 | — | — | EP | claimed |
| WO-2025096203-A1 | TARGETING A CHIMERIC RNA FOR TREATING CANCER | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025027492-A1 | CORONAVIRUS ANTIGEN VARIANTS | PFIZER INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| WO-2024133160-A1 | HEPATITIS B COMPOSITIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-06-27 | — | — | WO | disclosed |
| EP-4387596-A1 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | GlaxoSmithKline Biologicals SA (BE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024113009-A1 | AGENTS, COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024041772-A1 | RSV-F PROTEINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024041773-A1 | RSV-F PROTEINS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024035952-A1 | METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES | REMIX THERAPEUTICS INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| WO-2023242817-A2 | RECOMBINANT RNA MOLECULES COMPRISING UNTRANSLATED REGIONS OR SEGMENTS ENCODING SPIKE PROTEIN FROM THE OMICRON STRAIN OF SEVERE ACUTE RESPIRATORY CORONAVIRUS-2 | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2023-12-21 | — | — | WO | disclosed |
| EP-3188749-A1 | TOLEROGENIC COMPOSITIONS AND METHODS | Moderna Therapeutics, Inc. (US) | 2017-07-12 | — | — | EP | disclosed |
| WO-2017112943-A1 | METHODS OF USING OX40 LIGAND ENCODING POLYNUCLEOTIDES | MODERNATX, INC. (US) | 2017-06-29 | — | — | WO | disclosed |
| WO-2017106799-A1 | POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE | MODERNATX, INC. (US) | 2017-06-22 | — | — | WO | disclosed |
| EP-3052521-A1 | POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR | Moderna Therapeutics, Inc. (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2016036902-A1 | TOLEROGENIC COMPOSITIONS AND METHODS | MODERNA THERAPEUTICS, INC. (US) | 2016-03-10 | — | — | WO | disclosed |
| WO-2015051214-A1 | POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR | MODERNA THERAPEUTICS, INC. (US) | 2015-04-09 | — | — | WO | disclosed |
| US-20110020799-A1 | Screening method for damaged DNA repairing substance | NAGASAKI UNIVERSITY | 2011-01-27 | — | — | US | disclosed |
| EP-0365849-B1 | Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives | MERRELL DOW PHARMA (US) | 1994-09-14 | — | — | EP | disclosed |
| CN-1046334-A | New 2 '-halogenated methylene, 2 '-vinylidene and 2 '-the ethynyl adenosine derivative | MERRELL DOW PHARMA (US) | 1990-10-24 | — | — | CN | disclosed |
| EP-0365849-A2 | Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1990-05-02 | — | — | EP | disclosed |